- Home
- AMSF vs CGEM Comparison
AMSF vs CGEM Comparison
Compare AMSF & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSF
- CGEM
- Stock Information
- Founded
- AMSF 1985
- CGEM 2016
- Country
- AMSF United States
- CGEM United States
- Employees
- AMSF N/A
- CGEM N/A
- Industry
- AMSF Accident &Health Insurance
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- AMSF Finance
- CGEM Health Care
- Exchange
- AMSF Nasdaq
- CGEM Nasdaq
- Market Cap
- AMSF 984.1M
- CGEM 730.2M
- IPO Year
- AMSF 2005
- CGEM 2021
- Fundamental
- Price
- AMSF $51.24
- CGEM $12.39
- Analyst Decision
- AMSF Buy
- CGEM Strong Buy
- Analyst Count
- AMSF 2
- CGEM 7
- Target Price
- AMSF $59.50
- CGEM $31.67
- AVG Volume (30 Days)
- AMSF 134.8K
- CGEM 546.1K
- Earning Date
- AMSF 02-19-2025
- CGEM 11-07-2024
- Dividend Yield
- AMSF 2.90%
- CGEM N/A
- EPS Growth
- AMSF N/A
- CGEM N/A
- EPS
- AMSF 3.21
- CGEM N/A
- Revenue
- AMSF $315,182,000.00
- CGEM N/A
- Revenue This Year
- AMSF N/A
- CGEM N/A
- Revenue Next Year
- AMSF $0.88
- CGEM N/A
- P/E Ratio
- AMSF $15.88
- CGEM N/A
- Revenue Growth
- AMSF 2.81
- CGEM N/A
- 52 Week Low
- AMSF $41.97
- CGEM $10.00
- 52 Week High
- AMSF $60.24
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- AMSF 32.75
- CGEM 47.96
- Support Level
- AMSF $50.61
- CGEM $11.75
- Resistance Level
- AMSF $51.98
- CGEM $12.95
- Average True Range (ATR)
- AMSF 0.94
- CGEM 0.76
- MACD
- AMSF -0.16
- CGEM 0.19
- Stochastic Oscillator
- AMSF 14.93
- CGEM 77.69
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.